Vena CBD Review – Real Doses, Real THC, and a Subscription to Watch

Vena is a California CBD and wellness brand, operated under Medterra CBD LLC, selling functional gummies, capsules, tinctures and a CBD skincare line — products named for outcomes rather than ingredients: No Worries, Cloud 9, Lights Out, Rise + Shine. Two things set it apart from the six other hemp brands we have reviewed, and they pull in opposite directions. The botanicals are dosed at amounts that match the published research, which is rare. And each gummy carries 5mg of delta-9 THC — a genuinely psychoactive dose in a product sold in wellness language.

Overview

The range is organised by intended effect rather than by cannabinoid: No Worries for stress, Cloud 9 for mood, Lights Out and Restful Night for sleep, Rise + Shine for mornings, alongside full spectrum tinctures and capsules, a THC drink, and a skincare line including serums, moisturisers and a manuka cream.

That framing is the brand’s strength and its risk. The strength is that each formula pairs CBD with a specific active chosen for the stated purpose, at a disclosed dose. The risk is that outcome-named products in wellness packaging invite buyers to treat them as gentle supplements — and these are not gentle.

Everything below reflects Vena’s own product and FAQ pages as they read on 7 August 2026, its BBB record, published research on the botanicals used, and the statutory position on hemp. We have not bought or taken any of these products.

The Part Buyers Miss: 5mg of THC per Gummy

To be fair, the company discloses this clearly on the product panel — the milligrams are printed, and we found them without difficulty. This is not concealment. But the framing matters: a product called “No Worries” sold alongside facial serums and soaking salts sets an expectation of a mild botanical supplement, and a customer who takes two before a work call is in for a different afternoon than they planned.

Three practical consequences. Do not drive after taking one. You will likely fail a drug test — 5mg of delta-9 is not a borderline amount. And take half to start, particularly if you have not used edibles before, remembering that onset is delayed and the temptation to take more before the first has landed is exactly how people have a bad time.

The Formulation Is Better Than the Category Norm

Having spent several reviews criticising brands for proprietary blends with no disclosed amounts, we should be equally clear when someone does it properly. Vena publishes the dose of each active, and at least one of those doses is chosen with evident care.

Two honest qualifications, because the brief we work to requires efficacy figures to come with their population. That saffron research is largely in people with depressive symptoms, not healthy adults looking for a lift, and the effect sizes come from a clinical context. And these products are not sold, and cannot lawfully be sold, to treat depression — if you are depressed, that is a conversation for a clinician, not a gummy.

No Worries contains 100mg of L-theanine. That sits within the studied range but at its lower end: EEG research associates L-theanine with increased alpha activity and wakeful relaxation, single doses of 100, 200 and 400mg have been examined, and a randomised trial reporting reduced stress-related symptoms used 200mg a day. So 100mg is a real inclusion rather than a sprinkle, but it is half the dose of the stress trial — worth knowing if you are judging the product on that ingredient.

Where the Claims Outrun the Evidence

Cloud 9 also contains 250mg of L-tyrosine, and the page states the product “supports dopamine production.”

The first half of that is textbook: tyrosine genuinely is a precursor in the dopamine synthesis pathway. The problem is the implied second half — that taking more precursor produces more dopamine, and that more dopamine produces a better mood. In a healthy, adequately nourished person, neither step is reliable. The better-supported use of supplemental tyrosine is cognitive performance under acute stressors such as sleep deprivation or cold exposure, not mood elevation in ordinary conditions.

The claim is carefully worded — “supports” is doing a lot of work, and the required FDA disclaimer is present — so this is not a regulatory problem. It is an evidential one, and worth naming precisely because the saffron in the same product is well supported. The formulation would be more honest without it.

Pricing

At 3.5¢ per milligram subscribed, the CBD is mid-priced — dearer than R&R at 2.1¢ and far above Canna River at 0.5¢. But cost per milligram of CBD is the wrong yardstick here, because you are also buying 5mg of THC and a properly dosed botanical in each gummy. A fairer framing is that $52.46 buys 30 doses of a formulated product — about $1.75 a serving — which is reasonable for what is in it and expensive if you only wanted CBD.

A 30-day full refund is offered on products purchased within 30 days, and free shipping applies over $75 — which, at $69.95 a jar, is a threshold you clear by buying almost anything else.

Lab Testing

This is another area where Vena is stronger than the category norm. Coverage of the brand indicates the hemp distillate is tested before production and every finished batch is tested again by an external accredited laboratory, with screening for heavy metals, pesticides, residual solvents, mycotoxins and pathogens. The company’s own FAQ states its CBD and finished products are tested at a third-party laboratory for potency and purity.

Testing the input and the output separately is the right structure — plenty of brands test only the finished product, which cannot distinguish a clean batch from a lucky one. And mycotoxin and pathogen screening goes beyond what most competitors publish; mycotoxins are mould-derived and a genuine risk in plant material stored badly.

The Subscription Complaints

This needs stating carefully, because the numbers are small and it would be easy to make them sound worse than they are.

The Better Business Bureau profile for Vena CBD records five complaints across three years — a genuinely tiny number, with none closed in the last 12 months. Four relate to service or repair and one to sales and advertising. The company is not BBB accredited, and no letter rating was shown.

Five complaints is not evidence of a systemic billing problem, and we are not going to claim it is. But a recurring-revenue business where the small number of complaints that exist are almost all about cancellation, and almost all unanswered, is one where a buyer should take precautions that cost nothing: cancel through your account area rather than email, screenshot the confirmation, and check the next statement. Separately, Trustpilot coverage describes backorder problems with subscription orders prioritised ahead of one-time orders and delivery dates repeatedly pushed back — consistent with the tincture showing as sold out when we checked.

November 2026 and the THC Content

The same federal change we have flagged across this category applies here, and the high THC content makes the exposure unusually direct.

The practical advice given the subscription picture above is doubled here: do not set up a long-running subscription for a product category facing federal reclassification in roughly three months. Buy what you will use.

If You Are Here Because of Weight Loss

The THC content is the relevant point, and it is not incidental at 5mg a gummy. THC stimulates appetite — synthetic THC is an FDA-approved appetite stimulant — so a nightly gummy works directly against a GLP-1 medication or any deliberate appetite reduction. Our Summit THC review covers the pharmacology.

If stress or sleep is what you are actually trying to address — both of which genuinely affect appetite regulation, since short sleep raises ghrelin and lowers leptin — the honest observation is that you can buy L-theanine or saffron on their own, at the same doses, for a fraction of $69.95 and without the THC. That is a less profitable recommendation for this page, and it is the right one for a lot of readers.

Who Should Not Use These Products

This review is information, not medical advice, and nothing here promises any outcome. Speak to a clinician or pharmacist first, particularly given the botanical actives.

• Anyone pregnant or breastfeeding, or under 21.
• Anyone taking an antidepressant. Saffron has been studied for depressive symptoms and its mechanism is thought to involve serotonergic pathways, so combining it with an SSRI or SNRI is a conversation to have with your prescriber rather than a decision to make alone.
• Anyone taking thyroid medication or MAOIs — L-tyrosine is a precursor to both thyroid hormone and catecholamines, and interacts with both drug classes.
• Anyone on medication metabolised by the liver. CBD inhibits CYP3A4 and CYP2C19, affecting blood thinners, anticonvulsants and many others.
• Anyone with liver disease or raised liver enzymes.
• Anyone subject to drug testing — 5mg of delta-9 per gummy is not a trace.
• Anyone driving or operating machinery, or with a history of psychosis or significant anxiety.

Common CBD side effects include drowsiness, diarrhoea, appetite change and fatigue. Start with half a gummy.

How Vena Compares

Vena is the most thoughtfully formulated brand in this set and one of the two best on contaminant screening, but it is also the only one putting a real psychoactive THC dose into a product framed as everyday wellness. If you want a formulated mood or stress product and you are comfortable being mildly intoxicated by it, this is the strongest option we have reviewed. If you wanted CBD and nothing else, Soul’s isolate or R&R’s THC-free line are cheaper and do what you asked.

Pros and Cons

Who Should Pick It, and Who Should Look Elsewhere

Vena suits you if you want a formulated product rather than plain CBD, you care that the botanicals are dosed at researched amounts, and you are content that the result is mildly intoxicating. Cloud 9 is the pick of the range on evidence grounds, because 30mg of saffron is a real dose with real trials behind it. Buy a single jar rather than a subscription, and take half a gummy first.

Look elsewhere if you are drug tested, managing appetite on a GLP-1, or simply did not want THC — in which case an isolate or a THC-free broad spectrum product is cheaper and is what you actually asked for. Look elsewhere too if you take an antidepressant or thyroid medication without clearing the botanicals first. And if it is only the L-theanine or saffron you want, both are available on their own for a fraction of the price.

Limitations of This Review

We have not bought, taken or independently assayed any Vena product, so we cannot verify that a jar contains what its panel states, and we cannot speak to taste, effect, shipping or service. Everything above comes from Vena’s own product and FAQ pages as they read on 7 August 2026, its BBB record, published research on saffron, L-theanine and tyrosine, and the statutory position on hemp.

Specific gaps: the lab-testing detail — distillate plus batch testing, external accredited lab, and the mycotoxin and pathogen panel — is reported from third-party coverage rather than verified by us against certificates. We did not open any certificate of analysis. The tincture was sold out and its total milligram content was not stated, so we published no cost per milligram for it. We read the BBB complaint categories and themes but not every complaint in full, and complaint narratives are one-sided accounts; five complaints is a small sample from which we have deliberately drawn a limited conclusion. No BBB letter rating was shown. Trustpilot findings are third-party reported rather than read directly. The botanical research is drawn from published summaries rather than our own reading of the primary trials, and — importantly — the saffron trials studied clinical populations rather than the use these products are sold for. Nothing here is medical advice.

Frequently Asked Questions

Verdict

After six hemp reviews spent criticising undisclosed blends and doses chosen by marketing, Vena is a pleasant surprise. Putting 30mg of saffron in a mood product — the exact amount used in the randomised trials — and printing the number on the panel is the behaviour of someone who read the literature. The testing structure is right too: the input tested before production, every batch tested after, by an external accredited lab, screening for mycotoxins and pathogens as well as the usual metals and solvents.

Two things keep it out of the top tier. The first is a mismatch between packaging and pharmacology: 5mg of delta-9 THC per gummy is a real dose, and while it is printed clearly on the panel, nothing about a product called No Worries sitting beside a facial serum prepares a customer for being intoxicated by it. Take half to start, and do not drive.

The second is smaller in volume but sharper in shape. Five BBB complaints in three years is almost nothing — but four are unanswered and nearly all describe the same thing, a subscription that carried on charging after the customer asked it to stop. The written policy says cancel any time and we have no reason to doubt it is usually honoured. Still, on a business built on recurring orders, in a product category that federal law reclassifies on 12 November 2026, the sensible purchase here is one jar, not a standing order — and Cloud 9 is the one worth trying.